Drug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity con...

The much-awaited drug price control order (DPCO) 2013, meant to control the price of medicines does not cover over 80% of the medicines in ...

The drug pricing regulator, National Pharmaceutical Pricing Authority, on Monday issued a notification to regulate prices of 150-odd essent...

The policy, which will curtail prices of costly brands sold by domestic and international drugmakers, was approved by the government in Nov...

It will cover a wide range of drugs, such as anti-infectives (Cetrizine), cardiac (Aten) and gastro-intestinal medicines (Ocid), pain-kille...

Dr Reddy’s Laboratories’ revenues in the December quarter jumped to Rs 2,770 crore, buoyed by the launch of a star performing drug and a we...

The high cost of life-saving medicines is a major deterrent to healthcare in India. Availability of quality lowcost drugs will make healthc...

The government has asked the National Pharmaceutical Pricing Authority (NPPA) to keep a check on companies which factor in excise component...

The government is believed to be considering a proposal to free from price control about 5,000 small pharma companies having turnover of up...

Drug makers governments will soon face tough questions from the drug price regulator.

Government to bring 3 mass-use drugs under price control on which chemists take a hefty margin.

Popular drugs for treating bacterial infection, allergy and inflammation - on which chemists take huge margins and make them 20 times costl...

The proposed trade margin cut on generic drugs from October 2 is set to be applicable to 2,000 brands of specified strengths, and as a resu...

Prices of commonly used medicines such as paracetamol, nimesulide, cetrizine and omeprazole are set to come down sharply.

Drug makers who charge hefty margins will soon have to admit that.